key: cord-0926561-o3kdh28f
authors: Ianiro, Gianluca; Porcari, Serena; Settanni, Carlo Romano; Bibbò, Stefano; Ponziani, Francesca Romana; Zileri dal Verme, Lorenzo; Franceschi, Francesco; Cammarota, Giovanni; Gasbarrini, Antonio
title: Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID‐19
date: 2020-08-14
journal: Aliment Pharmacol Ther
DOI: 10.1111/apt.15946
sha: 0adc4cd4cb6f9ef606f779e2204aef46edad10d4
doc_id: 926561
cord_uid: o3kdh28f

LINKED CONTENT This article is linked to Tian et al and Tian and Rong papers. To view these articles, visit https://doi.org/10.1111/apt.15731 and https://doi.org/10.1111/apt.15986

In conclusion, this is the largest prospective Western cohort to describe the prevalence and patterns of gastrointestinal symptoms in patients with COVID-19 so far. Through a validated scoring system, we found that gastrointestinal symptoms are present in a large proportion of patients with COVID-19, but that they appear only after the start of COVID-19 related therapy in nearly a half of patients. We also found two different patterns of symptoms according to the timing of appearance (at admission vs after therapy). Finally, we found that gastrointestinal symptoms could predict a worse clinical picture. Further clinical and translational studies are advocated, respectively, to confirm our findings and to address their nature through a mechanicistic approach.

Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission

GSRS a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease